MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Online determination of the STN “sweet spot” based on beta-power measured with directional macro-contacts of the final DBS lead

    M. Scherer, L. Milosevic, R. Guggenberger, A. Malekmohammadi, G. Naros, D. Weiss, A. Gharabaghi (Tübingen, Germany)

    Objective: Microelectrode recordings are the standard procedure for intraoperative, electrophysiological mapping of the STN[1]. We investigated a novel methodology to detect the STN sweet spot…
  • 2019 International Congress

    Directional deep brain stimulation: what’s for?

    R. Zangaglia, B. Minafra, F. Bruschi, NG. Pozzi, F. Avantaggiato, C. Pacchetti (Pavia, Italy)

    Objective: to characterize the therapeutic window of ring and directional stimulation in subjects with PD and DBS of the subthalamic nucleus (STN) or the Globus…
  • 2019 International Congress

    “Poised for Parkinson’s”: Group classes in Alexander technique for managing symptoms of Parkinson’s disease

    M. Gross, R. Ravichandra, M. Norcia, R. Cohen (Moscow, ID, USA)

    Objective: To develop and test a group course using Alexander technique (AT) principles to improve functional mobility and quality of life for people living with…
  • 2019 International Congress

    The spectrum of involuntary vocalizations in humans

    T. Mainka, B. Balint, F. Gövert, L. Kurvits, C. van Riesen, A. Kühn, M. Tijssen, A. Lees, K. Müller-Vahl, K. Bhatia, C. Ganos (London, United Kingdom)

    Objective: To provide a detailed overview of the wide spectrum of involuntary vocalizations in humans, their etiologies and treatment recommendations. Background: Abnormal vocalizing behaviors are…
  • 2019 International Congress

    Assessment, identification and classification of movement disorders in 22q11.2 deletion syndrome

    W. Fung, A. Cunningham, T. Massey, J. Hall, M. Owen, M. Van-Den-Bree, K. Peall (Newport, United Kingdom)

    Objective: To assess the nature and frequency of movement disorders in children with molecularly confirmed 22q11.2 Deletion Syndrome. Background: 22q11.2 Deletion Syndrome (22q11.2DS) is a…
  • 2019 International Congress

    The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease

    Z. Akbarkhodjaeva, DJ. Tursunov (Tashkent, Uzbekistan)

    Objective: Learn the role of environmental toxins - rotenone in development of Parkinson's disease Background: Rotenone is a powerful pesticide. It is also a lipophilic…
  • 2019 International Congress

    The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease

    B. Bernard, G. Stebbins, A. Negron, D. Merkitch, J. Goldman (Chicago, IL, USA)

    Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…
  • 2019 International Congress

    The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease

    H. Combs, A. Strutt, J. Jimenez-Shahed, N. Niemann, A. Viswanathan, M. York (Houston, TX, USA)

    Objective: To develop a model to predict changes in impulse control symptom severity (ICSS) following deep brain stimulation (DBS) in patients with Parkinson’s disease (PD).…
  • 2019 International Congress

    Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease

    J. Goldman, S. Wu, C. Martinez-Rubio, V. Todaro (New York, NY, USA)

    Objective: To examine relationships among gender, care models, and presence and management of neuropsychiatric symptoms of Parkinson’s disease (PD). Background: Neuropsychiatric symptoms such as depression…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s Disease

    E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

    Objective: The objective is to study the relation between cognitive impairment with the form and stage of PD. Background: Currently, there is a tendency of…
  • « Previous Page
  • 1
  • …
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley